Transmission Potential and Design of Adequate Control Measures for Marburg Hemorrhagic Fever

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Ajelli, Marco ^a   Merler, Stefano ^a  

^a FONDAZIONE BRUNO KESSLER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ANGOLA; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISEASE TRANSMISSION; EPIDEMIC; FATALITY; GROWTH RATE; HEALTH CARE PLANNING; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFECTION CONTROL; MARBURG HEMORRHAGIC FEVER; MATHEMATICAL ANALYSIS; PROBABILITY; RISK ASSESSMENT; SIMULATION; SOCIAL DISTANCE; TREATMENT RESPONSE; VIRUS INFECTIVITY; VIRUS LOAD;

ANIMALS; BASIC REPRODUCTION NUMBER; EPIDEMICS; HUMANS; MARBURG VIRUS DISEASE; MODELS, BIOLOGICAL; TRAUMA SEVERITY INDICES;

PRIMATES;

EID: 84870935133     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050948     Document Type: Article

References (47)

1. Martini GA, (1973) Marburg virus disease. Postgrad Med J 49: 542-546.
2. Smith DH, Isaacson M, Johnson KM, Bagshawe A, (1982) Marburg-virus disease in Kenya. Lancet 319: 816-820.
3. Johnson ED, Johnson BK, Silverstein D, Tukei P, Geisbert TW, et al. (1996) Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol Supplement 11: 101-114.
4. Gear JS, Cassel GA, Gear AJ, Trappler B, Clausen L, et al. (1975) Outbreake of Marburg virus disease in Johannesburg. Br Med J 4: 489-493.
5. Borchert M, Muyembe-Tamfum JJ, Colebunders R, Libande M, Sabue M, et al. (2002) Short communication: A cluster of Marburg virus disease involving an infant. Trop Med Int Health 7: 902-906.
6. Bausch DG, Borchert M, Grein T, Roth C, Swanepoel R, et al. (2003) Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. Emerg Infect Dis 9: 1531-1537.
7. Ligon BL, (2005) Outbreak of Marburg Hemorrhagic Fever in Angola: A Review of the History of the Disease and its Biological Aspects. Semin Pediat Infect Dis 16: 219-224.
8. Jeffs B, Roddy P, Weatherill D, de la Rosa O, Dorion C, et al. (2007) The Médecins Sans Frontières intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005. I. Lessons learned in the hospital. J Infect Dis 196: S154-S161.
9. CDC (2009) Imported Case of Marburg Hemorrhagic Fever - Colorado, 2008. Morb Mortal Wkly Rep 58: 1377-1381.
10. Timen A, Koopmans MPG, Vossen ACTM, van Doornum GJJ, Günther S, et al. (2009) Response to imported case of Marburg hemorrhagic fever, the Netherlands. Emerg Infect Dis 15: 1171-1175.
11. Towner J, Pourrut X, Albariño C, Nkogue C, Bird B, et al. (2007) Marburg virus infection detected in a common African bat. PLoS ONE 2: e764.
12. Swanepoel R, Smit SB, Rollin PE, Formenty P, Leman PA, et al. (2007) Studies of Reservoir Hosts for Marburg Virus. Emerg Infect Dis 13: 1847-1851.
13. Towner J, Amman BR, Sealy TK, Carroll SAR, Comer JA, et al. (2009) Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats. PLoS Pathog 5: e1000536.
14. Negredo A, Palacios G, Vázquez-Morón S, González F, Dopazo H, et al. (2011) Discovery of an Ebolavirus-Like Filovirus in Europe. PLoS Pathog 7: e1002304.
15. World Health Organization (2008) Global Alert and Response- Marburg haemorrhagic fever. (Available at http://www.who.int/csr/don/archive/disease/marburg_virus_disease/en/).
16. Jones SM, Feldmann H, Ströher U, Geisbert JB, Fernando L, et al. (2005) Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 11: 786-790.
17. Daddario-Di Caprio KM, Geisbert TW, Ströher U, Geisbert JB, Grolla A, et al. (2006) Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet 367: 1399-1404.
18. Geisbert TW, Bausch DG, Feldmann H, (2010) Prospects for immunisation against Marburg and Ebola viruses. Rev Med Virol 20: 344-357.
19. Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, et al. (2002) Hemorrhagic Fever Viruses as Biological Weapons. J Am Med Assoc 287: 2391-2405.
20. Embassy of Angola (2011) Province of Uige (Available at http://www.angolaembassyindia.org/provinces.htm).
21. US Census Bureau (2012) International Data Base (Available at http://www.census.gov/population/international/data/idb/region.php).
22. Ferguson NM, Cummings DAT, Cauchemez S, Fraser C, Riley S, et al. (2005) Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437: 209-214.
23. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, (2006) Strategies for mitigating an influenza pandemic. Nature 442: 448-452.
24. Ciofi Degli Atti ML, Merler S, Rizzo C, Ajelli M, Massari M, et al. (2008) Mitigation Measures for Pandemic Influenza in Italy: An Individual Based Model Considering Different Scenarios. PLoS ONE 3: e1790.
25. Kolokol'tsov AA, Davidovich IA, Strel'tsova MA, Nesterov AE, Agafonova OA, et al. (2001) The use of interferon for emergency prophylaxis of Marburg hemorrhagic fever in monkeys. B Exp Biol Med 132: 686-688.
26. World Health Organization (2008) Marburg haemorrhagic fever. (Available at http://www.who.int/mediacentre/factsheets/fs_marburg/en/).
27. Anderson RM, May RM (1992) Infectious diseases of humans: dynamics and control. Oxford, UK: Oxford University Pres.
28. Wallinga J, Lipsitch M, (2007) How generation intervals shape the relationship between growth rates and reproductive numbers. Proc R Soc B 274: 599-604.
29. Chowell G, Hengartner NW, Castillo-Chavez C, Fenimore PW, Hyman JM, (2004) The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. J Theor Biol 229: 119-126.
30. Boëlle P, Bernillon P, Desenclos J (2009) A preliminary estimation of the reproduction ratio for new influenza A (H1N1) from the outbreak in Mexico, March-April 2009. Euro Surveill 14: pii = 19205.
31. Nishiura H, Castillo-Chavez C, Safan M, Chowell G (2009) Transmission potential of the new influenza A (H1N1) virus and its age-specificity in Japan. Euro Surveill 14: pii = 19227.
32. Merler S, Poletti P, Ajelli M, Caprile B, Manfredi P, (2008) Coinfection can trigger multiple pandemic waves. J Theor Biol 254: 499-507.
33. Rizzo C, Ajelli M, Merler S, Pugliese A, Barbetta I, et al. (2011) Epidemiology and transmission dynamics of the 1918-19 pandemic influenza in Florence, Italy. Vaccine 29: B27-B32.
34. Merler S, Ajelli M, (2010) The role of population heterogeneity and human mobility in the spread of pandemic influenza. Proc R Soc B 277: 557-565.
35. Merler S, Ajelli M, Pugliese A, Ferguson NM, (2011) Determinants of the Spatiotemporal Dynamics of the 2009 H1N1 Pandemic in Europe: Implications for Real-Time Modelling. PLoS Comput Biol 7: e1002205.
36. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, et al. (2009) Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings. Science 324: 1557-1561.
37. Baguelin M, Hoek AJV, Jit M, Flasche S, White PJ, et al. (2010) Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation. Vaccine 28: 2370-2384.
38. Ajelli M, Merler S, Pugliese A, Rizzo C, (2011) Model predictions and evaluation of possible control strategies for the 2009 A/H1N1v influenza pandemic in Italy. Epidemiol Infect 139: 68-79.
39. Colizza V, Barrat A, Barthelemy M, Vespignani A, (2007) Predictability and epidemic pathways in global outbreaks of infectious diseases: the SARS case study. BMC Med 5: 34.
40. Merler S, Ajelli M, Rizzo C, (2009) Age-prioritized use of antivirals during an influenza pandemic. BMC Infect Dis 9: 117.
41. Bettencourt LMA (2009) An Ensemble Trajectory Method for Real-Time Modeling and Prediction of Unfolding Epidemics: Analysis of the 2005 Marburg Fever Outbreak in Angola. In: Mathematical and Statistical Estimation Approaches in Epidemiology. 143-161.
42. World Health Organization (2008) Marburg haemorrhagic fever in Angola. (Available at http://www.who.int/csr/don/2005_03_23/en/index.html).
43. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, Borchert M, Rollin PE, et al. (2006) Marburg hemorrhagic fever associated with multiple genetic lineages of virus. New Eng J Med 355: 909-919.
44. Grolla A, Jones SM, Fernando L, Strong JE, Ströher U, et al. (2011) The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg outbreak in Angola. PLoS Negl Trop Dis 5: e1183.
45. Towner JS, Khristova ML, Sealy TK, Vincent MJ, Erickson BR, et al. (2006) Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol 80: 6497-6516.
46. Geisbert TW, Bailey M, Geisbert JB, Asiedu C, Roederer M, et al. (2010) Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates. J Virol 84: 10386-10394.
47. Fraser C, Riley S, Anderson RM, Ferguson NM, (2004) Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci USA 101: 6146-6151.